Effects of a Clinical Pathway on Treatment Outcomes for Older Adults with Fragile Pelvic Fractures
A Multicenter Stepped-Wedge Randomized Trial
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-06-24
393
Participants Needed
8
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Pelvic fragility fractures in elderly patients often lead to serious health problems and high death rates. Currently, treatment approaches vary widely due to the lack of a standard protocol. This trial evaluates a new clinical pathway based on evidence and expert experience, aiming to improve outcomes for this vulnerable group who face multiple risks for poor recovery.
The study compares the usual care with an evidence-based clinical pathway designed to guide diagnosis and treatment strategies. Patients will be randomly assigned to either continue with standard care or follow this best-practice clinical pathway. The pathway focuses on early diagnosis and minimally invasive treatments tailored for fragile patients.
Participants will be monitored over time to assess their mobility, daily function, quality of life, pain levels, medication use, complication rates, and mortality. Assessments use tools like the Parker mobility score, Elderly mobility scale, Katz Index, EuroQol quality of life questionnaire, and pain rating scales. Follow-ups occur at multiple intervals up to two years, with careful tracking of recovery and any additional injuries or complications.
CONDITIONS
Brief Title
Impact of a Clinical Pathway for Pelvic Fragility Fractures
Research Team
D
Daphne van Embden, MD, PhD
A
Anna H. Mennen, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead Sponsor
Noordwest Ziekenhuisgroep
Collaborating Sponsor
Who Can Participate
Age: 50Years +
All Genders
Eligibility Criteria
You may qualify if you...
Pelvic fragility fracture caused by low energetic trauma
Patients presented at the emergency room or out-patient clinic of a participating hospital
Age 50 years or older
You will not qualify if you...
High suspicion of pelvic fracture due to a malignant tumor
Severe cognitive decline preventing following instructions (e.g., dementia or Alzheimer's disease)
Receiving palliative or terminal care before the injury
Wheelchair bound or bedridden before the injury
Complications from previous pelvic ring fixation
Insufficient comprehension of Dutch to follow physiotherapy instructions
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Up to 1 year
Participants follow an evidence-based clinical pathway regarding the diagnostic and treatment strategy for pelvic fragility fractures.
Visits at baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study on Causes and Impact of Vulnerability in Adult Men With Serious Diseases Including Cancer and Fractures
Creating a Tool to Help Decide When to Use Abdominal-Pelvic CT Scans for Blunt Trauma Patients
Evaluation of Essential Amino Acid Supplementation for Muscle Recovery After Femoral Fragility Fractures
Study to Test a Digital Lifestyle Platform Supporting Adults After Inpatient Rehabilitation
Includes Patients with Heart, Lung, Bone, or Stroke Conditions
Study of Bone Damage and Fracture Patterns in Adults Undergoing Hip Replacement
Using Advanced Imaging and Computational Models to Understand Osteoporosis Effects
Effects of a Clinical Pathway on Treatment Outcomes for Older Adults with Fragile Pelvic Fractures
A Multicenter Stepped-Wedge Randomized Trial
Prospective Observational Study of Functional and Clinical Outcomes After Pelvic and Acetabular Fractures
Pilot Study of Precise Education and Shared Decision-Making to Prevent Fragility Fractures in Patients 50 and Older
Real World Outcomes Study of the iFuse TORQ TNT Device for Pelvic Fragility Fractures
Regional Anesthesia Techniques for Pain Management in Pelvic Fracture Surgery A Prospective Observational Study Comparing Regional Anesthesia and Multimodal Analgesia
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Does regional implementation of a clinical pathway for older adult patients with pelvic fragility fractures after low-energy trauma improve patient outcomes (PELVIC): a multicentre, stepped-wedge, randomised controlled trial.